Nyman D
Schweiz Med Wochenschr. 1975 Sep 13;105(37):1188-90.
Factor IX concentrates are of paramount importance in the treatment of hemophilia B. Growing reports of thromboembolic complications and of disseminated intravascular coagulation, coupled with the danger of hepatitis transmission, suggest that the concentrates should be primarily reserved for the treatment of hemophilia B. Concise guidelines for treatment are presented.
凝血因子IX浓缩剂在治疗乙型血友病中至关重要。关于血栓栓塞并发症和弥散性血管内凝血的报道日益增多，再加上肝炎传播的风险，这表明该浓缩剂应主要用于治疗乙型血友病。本文给出了简要的治疗指南。
